Table 4.

Biochemical outcomes at baseline and week 12.

	mRMR Group			eRMR Group
	n	Baseline	Week 12	n	Baseline	Week 12	Time Effect, p	Group Effect, p	Time-by-Group Interaction, p
Glucose (mmol/L)	23	5.0 ± 0.7	4.7 ± 0.7	22	5.4 ± 0.9	5.1 ± 0.8	p < 0.0005 *	p = 0.08	p = 0.74
TC (mmol/L)	23	4.5 ± 1.1	4.4 ± 1.0	20	4.1 ± 0.7	4.2 ± 0.9	p = 0.92	p = 0.18	p = 0.45
HDL (mmol/L)	23	1.4 ± 0.4	1.3 ± 0.4	21	1.4 ± 0.4	1.3 ± 0.3	p < 0.0005 *	p = 0.91	p = 0.15
TC:HDL Ratio	23	3.4 ± 0.9	3.6 ± 0.9	19	3.0 ± 0.6	3.2 ± 0.8	p = 0.09	p = 0.07	p = 0.87
LDL (mmol/L)	19	2.7 ± 0.7	2.6 ± 0.8	17	2.0 ± 0.6	2.3 ± 0.8	p = 0.43	p = 0.02 *	p = 0.28
TG (mmol/L)	20	1.2 ± 0.5	1.1 ± 0.4	18	1.3 ± 0.4	1.2 ± 0.4	p = 0.16	p = 0.63	p = 0.67

Values are presented as the mean ± SD. n = number of participants with complete data available for each outcome. p value obtained from a two-way mixed ANOVA test. TC, total cholesterol; HDL, high-density lipoprotein; TC:HDL, total cholesterol to high-density lipoprotein ratio; LDL, low-density lipoprotein; TG, triglycerides. *denotes significant difference, p < 0.05.